Northpond Ventures

United States$100K – $5M chequesUpdated May 2026

Embeds multi‑year research programs at top institutions, co‑runs labs and project selection, then converts academic IP into emerging ventures through negotiation, incorporation and syndication; prioritizes tools, platforms and biomanufacturing. With a disciplined investment approach, the team drives value for both founders and investors.

Cheque size: $100K – $5M
Stages: Series A
Industries: Healthcare
Operating in: United States
How they invest: Not specified
Technologies: Not specified

In the Nautis docs

Similar investors

Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.

Arkitekt Ventures

United States

95% match

Nascent-stage investor spanning service-heavy care delivery and deep neuro/bio/AR frontier tech, delivering specialized neuro+AI+delivery expertise that bridges physical clinics and cutting-edge technologies. With a disciplined investment approach, the team drives value for both founders and investors.

Invests at Series A
Healthcare
Active in United States

Seed and early-phase investor that creates and funds biotech young companies, emphasizing company creation. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.

Invests at Series A
Healthcare
Active in United States

Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.

Invests at Series A
Healthcare
Active in United States

Series AHealthcareTechnology

$500K – $1M

ARCH Venture Partners

United States

78% match

Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.

Invests at Series A
Healthcare
Active in United States

Series AHealthcareTechnology

Bioscience investor translating grant-funded research into venture-scale companies, with a pipeline centered on engineering biology using robotic cloud labs and computational design for human health and planetary sustainability. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.